However, in spite of this the government funded National Institute for Health Research has already put in two calls for trial ... CBD and Medical Cannabis Conference. A former journalist and ...

Aurora discovered a new source of genetic resistance against powdery mildew, a pathogen, in cannabis sativa. Given this discovery, the company is set to develop powdery mildew-resistant plants.

Aurora Cannabis Inc. (NASDAQ:ACB – Get Free Report) saw some unusual options trading on Thursday. Traders bought 4,976 call options on the stock. This is an increase of 39% compared to the typical ...

EDMONTON, AB, March 20, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to announce the Company's ...

EDMONTON, AB, March 20, 2025 /CNW/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to announce the Company's discovery of a ...

EDMONTON, Alberta – Aurora Cannabis Inc. (NYSE:NASDAQ:ACB), a Canadian company specializing in medicinal chemicals and botanical products with a market capitalization of $240 million ...

Aurora Cannabis shares jumped Thursday morning after the cannabis company said it has discovered a genetic resistance that protects its plants from crop disease. Shares rose 12% to 6.98 Canadian ...